THE CLINICAL, UTILITY AND ECONOMIC BENEFITS OF SECURING MINIMAL IMPORTANT DIFFERENCE IN ASTHMA CONTROL TEST USING A NOVEL TOOL: THE ABOVE ASTHMA (ACHIEVING-BETTER-OUTCOMES-AND-VALUE-FOR- EVERYBODY-IN-ASTHMA)

Manfrin A.; Tinelli M.

首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >THE CLINICAL, UTILITY AND ECONOMIC BENEFITS OF SECURING MINIMAL IMPORTANT DIFFERENCE IN ASTHMA CONTROL TEST USING A NOVEL TOOL: THE ABOVE ASTHMA (ACHIEVING-BETTER-OUTCOMES-AND-VALUE-FOR- EVERYBODY-IN-ASTHMA)

【24h】

THE CLINICAL, UTILITY AND ECONOMIC BENEFITS OF SECURING MINIMAL IMPORTANT DIFFERENCE IN ASTHMA CONTROL TEST USING A NOVEL TOOL: THE ABOVE ASTHMA (ACHIEVING-BETTER-OUTCOMES-AND-VALUE-FOR- EVERYBODY-IN-ASTHMA)

机译：使用小型工具确保哮喘控制试验最小差异的临床，效用和经济效益：上述哮喘（实现 - 达到更好的结果 - 价值 - 持续的哮喘）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thorax: The Journal of the British Thoracic Society》 |2017年第3期|共2页
作者
Manfrin A.; Tinelli M.;
展开▼
作者单位

Univ Greenwich Medway Sch Pharm Anson Bldg Chatham Kent England;

London Sch Econ &

Polit Sci LSE Hlth &

Social Care London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. THE CLINICAL, UTILITY AND ECONOMIC BENEFITS OF SECURING MINIMAL IMPORTANT DIFFERENCE IN ASTHMA CONTROL TEST USING A NOVEL TOOL: THE ABOVE ASTHMA (ACHIEVING-BETTER-OUTCOMES-AND-VALUE-FOR- EVERYBODY-IN-ASTHMA) [J] . Manfrin A., Tinelli M. Thorax: The Journal of the British Thoracic Society . 2017,第Suppla3期

机译：使用小型工具确保哮喘控制试验最小差异的临床，效用和经济效益：上述哮喘（实现 - 达到更好的结果 - 价值 - 持续的哮喘）
2. THE CLINICAL, UTILITY AND ECONOMIC BENEFITS OF SECURING MINIMAL IMPORTANT DIFFERENCE IN ASTHMA CONTROL TEST USING A NOVEL TOOL: THE ABOVE ASTHMA (ACHIEVING-BETTER-OUTCOMES-AND-VALUE-FOR- EVERYBODY-IN-ASTHMA) [J] . Manfrin A., Tinelli M. Thorax: The Journal of the British Thoracic Society . 2017,第Suppla3期

机译：使用小型工具确保哮喘控制试验最小差异的临床，效用和经济效益：上述哮喘（实现 - 达到更好的结果 - 价值 - 持续的哮喘）
3. The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): cross-cultural validation and relation with pollen counts [J] . Sander van der Leeuw, Thys van der Molen, PN Richard Dekhuijzen, Npj - Primary Care Respiratory Medicine . 2015,第1期

机译：控制变应性鼻炎和哮喘试验（CARAT）的最小临床重要性：跨文化验证以及与花粉数量的关系
4. ARE THERE ANY DIFFERENCES IN INDOOR ENVIRONMENT OF ASTHMATICS AND NON-ASTHMATICS PERSONS? A CASE/CONTROL STUDY PERFORMED IN SWEDEN AND ESTONIA [C] . M Frisk, A Raukas-Kivioja, H Andersson, International conference on indoor air quality and climate . 2002

机译：室内环境的哮喘和非哮喘人士有差异吗？在瑞典和爱沙尼亚进行了案例/对照研究
5. Efficacy of the Chinese herbal formula CUF2 in the treatment of childhood asthma: Animal experiment, in vitro study and randomized, double-blinded, placebo-controlled clinical trial. [D] . Wong, Yeuk Oi. 2006

机译：中药配方CUF2在治疗儿童哮喘中的功效：动物实验，体外研究以及随机，双盲，安慰剂对照的临床试验。
6. Novel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare provider [O] . Michela Tinelli, John White, Andrea Manfrin 2018

机译：由药剂师主导的新型干预措施可确保哮喘控制测试（ACT）分数的最低限度重要差异（MID）：为患者和医疗保健提供者带来更好的结果
7. Novel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare provider [O] . Michela Tinelli, John White, Andrea Manfrin 2018

机译：新型药剂师LED干预确保了哮喘控制测试（ACT）得分的微小重要差异（MID）：患者和医疗保健提供者的更好的结果

THE CLINICAL, UTILITY AND ECONOMIC BENEFITS OF SECURING MINIMAL IMPORTANT DIFFERENCE IN ASTHMA CONTROL TEST USING A NOVEL TOOL: THE ABOVE ASTHMA (ACHIEVING-BETTER-OUTCOMES-AND-VALUE-FOR- EVERYBODY-IN-ASTHMA)

著录项

相似文献

相关主题

期刊订阅